financetom
Business
financetom
/
Business
/
Flow Beverage Q2 Net Loss Widens; Paul Dowdall Appointed as Chief Financial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flow Beverage Q2 Net Loss Widens; Paul Dowdall Appointed as Chief Financial Officer
Jun 17, 2025 5:48 AM

08:16 AM EDT, 06/17/2025 (MT Newswires) -- Flow Beverage ( FLWBF ) on Tuesday reported a wider net loss in the second quarter and appointed Paul Dowdall as chief financial officer.

The company reported a net loss of $10.5 million for the three months ended April 30, compared with $7 million a year earlier. The adjusted net loss for the quarter was $7.1 million, compared with $6.3 million a year-ago.

Revenue for Q2 decreased to $10 million, compared with $12.1 million in the prior year. It also missed consensus estimate compiled by FactSet of $15 million.

Flow brand net revenue decreased 49% year-over-year to $3.6 million in Q2 due to the exit of commercial partnerships with retail and food service partners in order to meet its profitability targets and temporary disruptions to production and fulfillment due to working capital constraints. Planet A co-packing net revenue increased 28% in the quarter which offset the decrease in Flow brand net revenue.

Shares of the company closed up 11% to $0.10 on Monday on the Toronto Stock Exhange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NRX Pharmaceuticals Completes 12-Month Stability Test for Ketamine Product
NRX Pharmaceuticals Completes 12-Month Stability Test for Ketamine Product
Oct 2, 2024
07:50 AM EDT, 09/30/2024 (MT Newswires) -- NRX Pharmaceuticals ( NRXP ) said Monday that it has completed 12 months of demonstrating the stability of its first manufactured lot of NRX-100, or Ketamine, at Nephron Pharmaceuticals. NRX Pharmaceuticals ( NRXP ) said reaching the stability milestone will help support its submission of a new drug application with the US Food...
Reklaim Announces Normal Course Issuer Bid
Reklaim Announces Normal Course Issuer Bid
Oct 2, 2024
07:49 AM EDT, 09/30/2024 (MT Newswires) -- Reklaim ( MYIDF ) on Monday said the TSX Venture Exchange has approved the company's notice of intention to buy back up to 7.8 million of its common shares, comprising 10% of its public float. The buyback will start Monday, September 30, and run for one year. Reklaim ( MYIDF ) operates in...
Analysis-Google ad tech trial outcome no death blow, win or lose
Analysis-Google ad tech trial outcome no death blow, win or lose
Oct 2, 2024
SAN FRANCISCO - As Google's trial on allegations of building an illegal monopoly in advertising technology nears its close, experts said the financial risk of losing the case is minimal for the tech giant best known for its search engine.  The U.S. Department of Justice and a coalition of states accuse the Alphabet unit of illegally monopolizing markets for the...
Top Premarket Gainers
Top Premarket Gainers
Oct 2, 2024
07:51 AM EDT, 09/30/2024 (MT Newswires) -- Zhongchao ( ZCMD ) shares surged 87% pre-bell Monday following a muted session. TTEC Holdings ( TTEC ) shares were up 35% after the company said it received an unsolicited takeover proposal from its chief executive officer. OneConnect (OCFT) shares increased 17%, extending Friday's rally. Reliance Global (RELI) shares advanced 20% after Friday's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved